Allstate Corp Catalent, Inc. Transaction History

Allstate Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$72.36 - $113.1 $6,946 - $10,857	-96 Reduced 1.2%	7,893 $571,000
Q2 2022 Aug 15, 2022	SELL	$87.2 - $114.05 $876,447 - $1.15 Million	-10,051 Reduced 55.72%	7,989 $857,000
Q1 2022 May 16, 2022	SELL	$94.19 - $124.49 $633,898 - $837,817	-6,730 Reduced 27.17%	18,040 $2 Million
Q4 2021 Feb 15, 2022	BUY	$119.57 - $139.07 $2.96 Million - $3.44 Million	24,770 New	24,770 $3.17 Million
Q2 2021 Aug 16, 2021	SELL	$100.34 - $115.69 $222,152 - $256,137	-2,214 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$101.51 - $125.27 $1.03 Million - $1.27 Million	-10,132 Reduced 82.07%	2,214 $233,000
Q4 2020 Feb 12, 2021	SELL	$85.88 - $105.36 $439,619 - $539,337	-5,119 Reduced 29.31%	12,346 $1.29 Million
Q3 2020 Nov 13, 2020	SELL	$72.74 - $92.5 $1.27 Million - $1.62 Million	-17,468 Reduced 50.0%	17,465 $1.5 Million
Q2 2020 Aug 13, 2020	SELL	$48.02 - $79.04 $184,060 - $302,960	-3,833 Reduced 9.89%	34,933 $2.56 Million
Q1 2020 May 15, 2020	SELL	$36.95 - $62.95 $393,850 - $670,984	-10,659 Reduced 21.57%	38,766 $2.01 Million
Q4 2019 Feb 14, 2020	BUY	$47.06 - $56.64 $2.33 Million - $2.8 Million	49,425 New	49,425 $2.78 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

Stay updated on Allstate Corp with notifications on news.